These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8374698)

  • 21. The effect of adenine on platelet storage.
    Wong SC; Rock G
    Transfusion; 1982; 22(4):283-7. PubMed ID: 7101420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogen reduction technology (Mirasol) treated single-donor platelets resuspended in a mixture of autologous plasma and PAS.
    Janetzko K; Hinz K; Marschner S; Goodrich R; Klüter H
    Vox Sang; 2009 Oct; 97(3):234-9. PubMed ID: 19790298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet storage lesion in second-generation containers: correlation with platelet ATP levels.
    Holme S; Heaton WA; Courtright M
    Vox Sang; 1987; 53(4):214-20. PubMed ID: 3125686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet storage in PAS-2 or autologous plasma: impact on functional parameters.
    Bunescu A; Hild M; Lundahl J; Egberg N
    Transfus Med; 2001 Apr; 11(2):105-10. PubMed ID: 11299027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
    Sandgren P; Mayaudon V; Payrat JM; Sjödin A; Gulliksson H
    Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro analysis of volume-reduced washed platelet concentrates stored in bicarbonated Ringer's solution containing less than 5% residual plasma.
    Oikawa S; Minegishi M; Endo K; Kawashima W; Suzuki K; Shimizu H
    Vox Sang; 2016 Jul; 111(1):16-21. PubMed ID: 26918327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro evaluation of buffy-coat-derived platelet concentrates stored in a synthetic medium.
    Fijnheer R; Veldman HA; van den Eertwegh AJ; Gouwerok CW; Homburg CH; Boomgaard MN; de Korte D; Roos D
    Vox Sang; 1991; 60(1):16-22. PubMed ID: 2053325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extension of platelet concentrate storage by addition of sodium bicarbonate.
    Shah GA; Lenferink JC
    Transfusion; 1985; 25(2):162-4. PubMed ID: 2984809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-day storage of human platelet concentrates in 30 ml of plasma or artificial medium.
    Adams GA; Swenson SD; Rock G
    Vox Sang; 1987; 52(4):305-12. PubMed ID: 3630056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ultrastructural changes and activation differences in platelet concentrates stored in plasma and additive solution.
    Wagner T; Vetter A; Dimovic N; Guber SE; Helmberg W; Kröll W; Lanzer G; Mayr WR; Neumüller J
    Transfusion; 2002 Jun; 42(6):719-27. PubMed ID: 12147024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fuel choices by human platelets in human plasma.
    Guppy M; Abas L; Neylon C; Whisson ME; Whitham S; Pethick DW; Niu X
    Eur J Biochem; 1997 Feb; 244(1):161-7. PubMed ID: 9063460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aggregation response of human platelets stored at 22 C as platelet-rich plasma.
    Moroff G; Chang CH
    Transfusion; 1979; 19(6):704-18. PubMed ID: 42998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of a new citrate-acetate-NaCl platelet additive solution for the storage of white cell-reduced platelet concentrates obtained from half-strength CPD pooled buffy coats.
    van Rhenen DJ; Vermeij H; Kappers-Klunne M; Payrat JM
    Transfusion; 1995 Jan; 35(1):50-3. PubMed ID: 7998070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of recombinant human megakaryocyte growth and development factor coupled with polyethylene glycol on the platelet storage lesion.
    Snyder E; Perrotta P; Rinder H; Baril L; Nichol J; Gilligan D
    Transfusion; 1999 Mar; 39(3):258-64. PubMed ID: 10204587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic energy reduction by glucose deprivation and low gas exchange preserves platelet function after 48 h storage at 4 degrees C.
    Badlou BA; van der Meer PF; Akkerman JW; Smid WM; Pietersz RN
    Vox Sang; 2007 May; 92(4):311-8. PubMed ID: 17456155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units.
    Picker SM; Steisel A; Gathof BS
    Transfusion; 2008 Aug; 48(8):1685-92. PubMed ID: 18513255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of platelets stored in CDP-adenine formulations.
    Bolin RB; Cheney BA; Simpliciano OA; Peck CC
    Transfusion; 1980; 20(4):409-18. PubMed ID: 7404639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid-preserved, and cryopreserved human platelets: effect of agonists, pH, and plasma and saline resuspension.
    Valeri CR; Macgregor H; Ragno G
    Transfusion; 2005 Apr; 45(4):596-603. PubMed ID: 15819682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Additive solutions differentially affect metabolic and functional parameters of platelet concentrates.
    Leitner GC; List J; Horvath M; Eichelberger B; Panzer S; Jilma-Stohlawetz P
    Vox Sang; 2016 Jan; 110(1):20-6. PubMed ID: 26274931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelets stored in a glucose-free additive solution or in autologous plasma--an ultrastructural and morphometric evaluation.
    Klinger MH; Josch M; Klüter H
    Vox Sang; 1996; 71(1):13-20. PubMed ID: 8837351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.